Flurpiridaz F 18

Overview

Flurpiridaz F 18 is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2107799).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Flurpiridaz F 18 expires 13 May 2042 and exclusivity 27 Sept 2029. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

2-tert-butyl-4-chloro-5-[[4-(2-(18F)fluoroethoxymethyl)phenyl]methoxy]pyridazin-3-one

Canonical SMILES

CC(C)(C)N1C(=O)C(=C(C=N1)OCC2=CC=C(C=C2)COCC[18F])Cl

InChIKey

RMXZKEPDYBTFOS-LRFGSCOBSA-N